These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
3. Advances in NURR1-Regulated Neuroinflammation Associated with Parkinson's Disease. Al-Nusaif M; Lin Y; Li T; Cheng C; Le W Int J Mol Sci; 2022 Dec; 23(24):. PubMed ID: 36555826 [TBL] [Abstract][Full Text] [Related]
4. Microbiome-Gut-Brain Axis and Toll-Like Receptors in Parkinson's Disease. Caputi V; Giron MC Int J Mol Sci; 2018 Jun; 19(6):. PubMed ID: 29882798 [TBL] [Abstract][Full Text] [Related]
5. T-Cell-Driven Inflammation as a Mediator of the Gut-Brain Axis Involved in Parkinson's Disease. Campos-Acuña J; Elgueta D; Pacheco R Front Immunol; 2019; 10():239. PubMed ID: 30828335 [TBL] [Abstract][Full Text] [Related]
6. Gut Microbiota: A Novel Therapeutic Target for Parkinson's Disease. Zhu M; Liu X; Ye Y; Yan X; Cheng Y; Zhao L; Chen F; Ling Z Front Immunol; 2022; 13():937555. PubMed ID: 35812394 [TBL] [Abstract][Full Text] [Related]
7. Inhibition of the JAK/STAT Pathway Protects Against α-Synuclein-Induced Neuroinflammation and Dopaminergic Neurodegeneration. Qin H; Buckley JA; Li X; Liu Y; Fox TH; Meares GP; Yu H; Yan Z; Harms AS; Li Y; Standaert DG; Benveniste EN J Neurosci; 2016 May; 36(18):5144-59. PubMed ID: 27147665 [TBL] [Abstract][Full Text] [Related]
8. Neuroinflammation in Parkinson's Disease: Triggers, Mechanisms, and Immunotherapies. Wang T; Shi C; Luo H; Zheng H; Fan L; Tang M; Su Y; Yang J; Mao C; Xu Y Neuroscientist; 2022 Aug; 28(4):364-381. PubMed ID: 33576313 [TBL] [Abstract][Full Text] [Related]
9. Gastrointestinal dysfunction in Parkinson's disease: molecular pathology and implications of gut microbiome, probiotics, and fecal microbiota transplantation. Metta V; Leta V; Mrudula KR; Prashanth LK; Goyal V; Borgohain R; Chung-Faye G; Chaudhuri KR J Neurol; 2022 Mar; 269(3):1154-1163. PubMed ID: 33881598 [TBL] [Abstract][Full Text] [Related]
10. Brain-gut-microbiota axis in Parkinson's disease. Mulak A; Bonaz B World J Gastroenterol; 2015 Oct; 21(37):10609-20. PubMed ID: 26457021 [TBL] [Abstract][Full Text] [Related]
16. Dysregulation of the Gut-Brain Axis, Dysbiosis and Influence of Numerous Factors on Gut Microbiota Associated Parkinson's Disease. Kaur G; Behl T; Bungau S; Kumar A; Uddin MS; Mehta V; Zengin G; Mathew B; Shah MA; Arora S Curr Neuropharmacol; 2021; 19(2):233-247. PubMed ID: 32504503 [TBL] [Abstract][Full Text] [Related]
17. Emerging insights between gut microbiome dysbiosis and Parkinson's disease: Pathogenic and clinical relevance. Bi M; Feng L; He J; Liu C; Wang Y; Jiang H; Liu SJ Ageing Res Rev; 2022 Dec; 82():101759. PubMed ID: 36243356 [TBL] [Abstract][Full Text] [Related]
18. The Interplay between Gut Microbiota and Parkinson's Disease: Implications on Diagnosis and Treatment. Varesi A; Campagnoli LIM; Fahmideh F; Pierella E; Romeo M; Ricevuti G; Nicoletta M; Chirumbolo S; Pascale A Int J Mol Sci; 2022 Oct; 23(20):. PubMed ID: 36293176 [TBL] [Abstract][Full Text] [Related]
19. Reducing neuroinflammation via therapeutic compounds and lifestyle to prevent or delay progression of Parkinson's disease. Kip E; Parr-Brownlie LC Ageing Res Rev; 2022 Jun; 78():101618. PubMed ID: 35395416 [TBL] [Abstract][Full Text] [Related]
20. Role of enteric glia and microbiota-gut-brain axis in parkinson disease pathogenesis. Claudino Dos Santos JC; Lima MPP; Brito GAC; Viana GSB Ageing Res Rev; 2023 Feb; 84():101812. PubMed ID: 36455790 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]